Axa S.A. Moderna, Inc. Transaction History

Axa S.A.

$32.8 Billion
Q1 2024

A detailed history of Axa S.A. transactions in Moderna, Inc. stock. As of the latest transaction made, Axa S.A. holds 203,042 shares of MRNA stock, worth $23.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

203,042

Previous 474,552 57.21%

Holding current value

$23.8 Million

Previous $47.2 Million 54.16%

% of portfolio

0.07%

Previous 0.16%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $23.2 Million - $31.3 Million	-271,510 Reduced 57.21%	203,042 $21.6 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $8.93 Million - $13.4 Million	-128,488 Reduced 21.31%	474,552 $47.2 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $10.6 Million - $13.9 Million	109,999 Added 22.31%	603,040 $62.3 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $13.5 Million - $18.2 Million	113,540 Added 29.92%	493,041 $59.9 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $20 Million - $29 Million	-147,412 Reduced 27.98%	379,501 $58.3 Million

Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $34.5 Million - $61.2 Million	291,235 Added 123.57%	526,913 $94.6 Million
Q3 2022 Feb 14, 2023	BUY	$118.07 - $194.18 $13 Million - $21.4 Million	110,303 Added 87.98%	235,678 $27.9 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $13 Million - $21.4 Million	110,303 Added 87.98%	235,678 $27.9 Million
Q2 2022 Feb 14, 2023	SELL	$117.13 - $176.59 $260,497 - $392,736	-2,224 Reduced 1.74%	125,375 $17.9 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $260,497 - $392,736	-2,224 Reduced 1.74%	125,375 $17.9 Million
Q1 2022 Feb 14, 2023	SELL	$126.46 - $235.05 $13.7 Million - $25.4 Million	-108,079 Reduced 45.86%	127,599 $22 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $4.36 Million - $8.1 Million	34,472 Added 37.02%	127,599 $22 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $8.46 Million - $13.8 Million	-37,470 Reduced 28.69%	93,127 $23.7 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $4.89 Million - $10.7 Million	-22,023 Reduced 14.43%	130,597 $50.3 Million
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $2.26 Million - $4.09 Million	-17,418 Reduced 10.24%	152,620 $35.9 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $345,008 - $587,696	3,160 Added 1.89%	170,038 $22.3 Million
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $249,154 - $643,769	3,790 Added 2.32%	166,878 $17.4 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $82,216 - $143,508	1,513 Added 0.94%	163,088 $11.5 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $94,380 - $254,480	3,181 Added 2.01%	161,575 $10.4 Million
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $2.82 Million - $5 Million	158,394 New	158,394 $4.74 Million

Others Institutions Holding MRNA

# of Institutions

1,037

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account